Active Pharmaceutical Ingredients
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis (eg, osteoarthritis, rheumatoid arthritis, or juvenile rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain.
| Component | Function |
|---|---|
| Celecoxib | Active Ingredient (COX-2 selective NSAID) |
| Mannitol / Lactose Monohydrate | Diluent / Filler |
| Povidone (PVP K30) | Binder / Solubility Enhancer |
| Croscarmellose Sodium / Crospovidone | Disintegrant |
| Sodium Lauryl Sulfate (SLS) | Wetting Agent to enhance solubility |
| Magnesium Stearate | Lubricant |
| Colloidal Silicon Dioxide | Glidant |
Outsourcing DC Granules through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading developer aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Celecoxib Premix or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Celecoxib Premix is designed to improve content uniformity and processability of poorly soluble APIs, helping formulators achieve consistent dosage in oral solid formulations.
Yes. As a pre-blended formulation, it reduces the need for extensive excipient selection and compatibility studies, enabling faster product development and scale-up.
The premix can be used for tablet compression or capsule filling, offering flexibility for manufacturers developing multiple dosage forms.
Each batch undergoes blend uniformity testing, particle size control, and validated analytical testing to ensure consistent performance and compliance with pharmaceutical quality standards.